Targeted Radiopharmaceuticals Are Reshaping Precision Cancer Therapy
A new review maps how target-specific radiopharmaceuticals pair matched diagnostic and therapeutic radionuclides to deliver precision cancer therapy from imaging ...
A new review maps how target-specific radiopharmaceuticals pair matched diagnostic and therapeutic radionuclides to deliver precision cancer therapy from imaging ...
An integrated in silico and in vitro study finds that clinically used fluorinated PSMA PET radiopharmaceuticals share a conserved binding ...
A systematic screen of 19 fluorobenzene derivatives shows that electron-withdrawing nitro and nitrile groups, especially at ortho and para positions, ...
Monte Carlo simulations show that alpha particles from the actinium-225 decay chain dominate tumor dose delivery and that retaining bismuth-213 ...
Researchers report a scalable two-stage chromatographic process that yields high-purity, no-carrier-added terbium-161 from enriched gadolinium-160 targets with quality specifications suitable ...
A position paper argues that radiochemical robustness, not just peak radiochemical yield, should be a co-equal design criterion in radiopharmaceutical ...
A narrative review argues that the imaging modality—PET, SPECT, ultrasound, MRI, CT, or optical—fundamentally determines the design, mechanism, and clinical ...
A Swedish observational cohort study of 167 patient administrations found that residual radiopharmaceutical activity in venous access devices was generally ...
A new review proposes a conditional treatment sequence for Waldenström macroglobulinemia, from frontline options to choices after covalent BTK inhibitor ...
A preclinical study reports that 213Bi-labeled trastuzumab plus cetuximab killed human bladder cancer cells in vitro through irreparable DNA damage.
A Nature Reviews Cancer review argues that theranostics should expand beyond radiolabelled peptides to include nanotheranostics, microtheranostics and imaging-guided surgery.
A preclinical SPECT study found that 8 MBq of a 177Lu-labelled peptide suffices for good mouse tumour image quality up ...
A review published in EJNMMI Radiopharmacy and Chemistry compares how the FDA, EMA and NMPA evaluate radiopharmaceuticals before clinical use ...
Researchers report an optimized scandium-44 production and separation method achieving radionuclidic purity above 99 percent and automated DOTATOC labelling with ...
A comparison of automated production processes for three therapeutic radiopharmaceuticals suggests solid phase extraction purification may be dispensable in some ...
The Editorial Board of EJNMMI Radiopharmacy and Chemistry highlights 23 developments from early 2026 spanning novel chelators, PET tracers, radiofluorination ...
A retrospective analysis of Brazil's VigiMed database identified 191 radiopharmaceutical drug entries in 126 adverse event reports, with Xofigo and ...
Researchers report a solid-phase synthesised DFO analog whose gallium-68 and zirconium-89 complexes show high stability, rapid renal clearance and negligible ...
Radiolabeled atezolizumab with lutetium-177 significantly reduced tumor volumes and extended median survival in a mouse model of triple-negative breast cancer.
A new review examines how genetically engineered elastin-like polypeptides, with tunable sequences and thermoresponsive phase behavior, could serve as programmable ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.